Transcell Oncologics Private Limited - Company Profile

It is a research & development private limited company based in Hyderabad, Telangana, India, established in 2017.
2017 Hyderabad, Telangana, India Amalgamated
Last Updated:
Access Report
About Transcell Oncologics Private Limited

Transcell Oncologics Private Limited, a amalgamated private limited company, was established on 02 August 2017 in Hyderabad, Telangana, India. Engaging in research & development within the professional, scientific and technical sector, it holds CIN: U74999TG2017PTC118680. Registered under ROC Roc Hyderabad. it is unlisted. It has an authorized capital of ₹0.15 M and a paid-up capital of ₹0.13 M.

It upholds a compliant status. Its leadership includes Uday Chatterjee (Director), Vinayender Tulla (Director), Subhadra Dravida (Director). Past directors included Uday Chatterjee. It holds no open charges and ₹2.70 M settled loans. Its latest AGM occurred on 30 September 2023, with the balance sheet filed on 31 March 2023. It is based at 8Th Floor Western Pearl, Kondapur, Hyderabad, Telangana, 500084.

Company Details
  • Email
    **********
  • Telephone

    +91-XXXXXXXXXX

  • Website
    **********
  • Social Media
    **********
  • Apps
    **********

Company Details

  • CIN/LLPIN

    U74999TG2017PTC118680

  • Registration Number

    118680

  • Incorporation Date

    02 August 2017

  • Authorized Capital

    ₹0.15 M

  • Paid-Up Capital

    ₹0.13 M

  • ROC Code

    Roc Hyderabad

  • Listing Status

    Unlisted

  • Company Status

    Amalgamated

Key Metrics
  • Authorised Capital ₹ 0.15 M
  • Paid Up Capital ₹ 0.13 M
  • Company Age 8 Year, 6 Months
  • Last Filing with ROC 31 Mar 2023
  • Satisfied Charges ₹ 2.70 M
  • Revenue Growth **** -29.63%
  • Profit Growth **** 9.71%
  • Ebitda **** 39.03%
  • Net Worth -30.08%
  • Total Assets -12.49%
Company report

Transcell Oncologics Private Limited

Company Report FY 2025-2026

Comprehensive Company Insights

Explore comprehensive insights into Transcell Oncologics Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.

Access Report Banner Element
Who are the key members and board of directors at Transcell Oncologics Private Limited?
Current Directors
Name Designation Appointment Date Status
Uday Chatterjee Director 05 Jul 2021 Current
Vinayender Tulla Director 02 Aug 2017 Current
Subhadra Dravida Director 02 Aug 2017 Current
Past Directors
Name Designation Cessation Status
Pramod Abcsdd Additional Director 30 Nov 2021 Past

Discover detailed profiles of directors and KMP - Unlock leadership insights today!

Financial Performance of Transcell Oncologics.

Transcell Oncologics Private Limited, for the financial year ended 2021, experienced significant reduction in revenue, with a 29.63% decrease. The company also saw a slight improvement in profitability, with a 9.71% increase in profit. The company's net worth observed a substantial decline by a decrease of 30.08%.

Transcell Oncologics revenue growth over time
Transcell Oncologics profit and loss trends over time
Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors
Emtek
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
Jan, 2021 Amount Post-IPO - Grab Valuation

investors
Hana Financial Group , GGV Capital
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
  • Key Matrics
  • Balance Sheet
  • Profit and Loss
  • Cash Flow
  • Ratios
Metrics
(FY 2023) YOY Growth
(FY 2022) (FY 2021) (FY 2020) (FY 2019)
Total Revenue
********
 -29.63%
*******
*******
*******
*******
Revenue from Operations
*******
 -29.49%
*******
*******
*******
*******
Total Assets
*******
 -12.49%
*******
*******
*******
*******
Profit or Loss
*******
 9.71%
*******
*******
*******
*******
Net Worth
*******
 -30.08%
*******
*******
*******
*******
EBITDA
*******
 39.03%
*******
*******
*******
*******

Discover detailed financial data and - Unlock financial today!

What is the Ownership and Shareholding Structure of Transcell Oncologics?

In 2021, Transcell Oncologics had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.

Shareholding Pattern (FY 2024)
shareholding
  • Promoters: 92.83%
  • Public: 4.10%
  • Others: 3.07%
Shareholding Pattern over the Year
FY (2024) FY (2023) FY (2022) FY (2021) FY (2020)
Promoters 92.83 94.62 94.55 94.55 94.55
Public 4.10 3.89 3.95 3.96 3.98
Others 3.07 1.49 1.50 1.49 1.47

Reveal ownership structures and financial performance - Get instant access now!

Charges (Loans)
Open Charges

₹0

Satisfied Charges

₹2,700,000.00

Charges Breakdown by Lending Institutions
  • Hdfc Bank Limited : 0.27 Cr
Latest Charge Details
Date Lender Amount Status
08 Jul 2021 Hdfc Bank Limited ₹2.70 M Satisfied

Explore comprehensive loan charge details -

How Many Employees Work at Transcell Oncologics?

Unlock and access historical data on people associated with Transcell Oncologics, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.

Employee Date Number of Employees
2020 78,000
2021 80,500
2022 83,200
2023 86,000
2024 89,500
2025 92,000
Deals i
Graph showing company valuation over time

Gain comprehensive insights into the Deals and Valuation data of Transcell Oncologics, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Transcell Oncologics's trajectory.

Rating
Graph displaying rating trends over time

Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.

Alerts
Alert Indicator

Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.

Explore deal ratings and alerts - Get instant access now!

Latest Updates, News, and FAQs on Transcell Oncologics
Recent Activity within the Organization
  • Charges

    Progress on A charge registered on 08 Jul 2021 via Charge ID 100470061 with Hdfc Bank Limited was fully satisfied on 13 Oct 2023. was documented.

  • Annual General Meeting

    Progress on Transcell Oncologics Private Limited last Annual general meeting of members was held on 30 Sep 2023 as per latest MCA records. was documented.

  • Balance Sheet

    Progress on Transcell Oncologics Private Limited has filed its annual Financial statements for the year ended 31 Mar 2023 with Roc Hyderabad. was documented.

  • Charges

    The activity A charge with Hdfc Bank Limited amounted to Rs. 2.70 M with Charge ID 100470061 was registered on 08 Jul 2021. was completed.

  • Director Appointment

    Uday Chatterjee was appointed as a Director was appointed as a Director on 05 Jul 2021 & has been associated with this company since 4 years 7 months . was recorded as a recent event.

  • Director Appointment

    Vinayender Tulla was appointed as a Director was appointed as a Director on 02 Aug 2017 & has been associated with this company since 8 years 6 months . was recorded as a recent event.

Explore recent activity and updates - View Recent Activity

Frequently Asked Questions
What is the CIN of Transcell Oncologics Private Limited?

The CIN of Transcell Oncologics Private Limited is U74999TG2017PTC118680.

Where is Transcell Oncologics Private Limited headquartered?

Transcell Oncologics Private Limited is headquartered at 8Th Floor Western Pearl, Kondapur, Hyderabad, Telangana, 500084.

When was Transcell Oncologics Private Limited incorporated?

Transcell Oncologics Private Limited was incorporated on 02 August 2017.

Who are the current directors of Transcell Oncologics Private Limited?

The current directors of Transcell Oncologics Private Limited are

What is the primary industry of Transcell Oncologics Private Limited?

The primary industry of Transcell Oncologics Private Limited is Professional, Scientific And Technical.

Is Transcell Oncologics Private Limited a listed company?

Transcell Oncologics Private Limited is unlisted.

What is the capital structure of Transcell Oncologics Private Limited?

The authorized capital of Transcell Oncologics Private Limited is ₹0.15 M, and the paid-up capital is ₹0.13 M.

What is the compliance status of Transcell Oncologics Private Limited?

The compliance status of Transcell Oncologics Private Limited is Compliant.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available